🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Beta Bionics, Inc.

BBNX Healthcare
$17.73 $-0.35 (-1.91%)
Market Cap: $797.89 M
Gurus Holding
5
Popularity Rank
#2093
% of Shares Held
7.74%
Net Activity (Q2 2026)
-$445,719

Guru Ownership Trend

Guru Analysis for Beta Bionics, Inc. (BBNX)

Beta Bionics, Inc. (BBNX), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $61.72 M.

Top institutional holders include Steven Cohen and Robert Bruce.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $445,719 net outflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 155.7%. Conversely, Paul Tudor Jones reduced exposure by 16.0%.

Key Holders

Top 5 by Value

Recent Activity Breakdown (Q2 2026)

+$1.98 M
Total Buy Value
New Buys 1
Additions 1
-$2.42 M
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Beta Bionics, Inc. (BBNX)

Major holders include Steven Cohen ($25.3 M), Robert Bruce ($10.43 M), Paul Tudor Jones ($2.19 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 3.48 M shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $445,719, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited BBNX. The total reported sell value was $2.42 M.

Yes, 1 managers opened new positions in BBNX, and 1 increased their existing holdings. The total reported buy value was $1.98 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.03% Add 155.7% 2,525,040 $25.3 M Q1 2026
2.82% Add 20.9% 665,700 $10.43 M Q2 2026
0.00% Reduce -16.0% 218,094 $2.19 M Q1 2026
0.00% Add 19.6% 60,287 $604,075 Q1 2026
0.00% New Buy 11,300 $177,071 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form